Is 5-Amino-1MQ a peptide?

No. It is a small-molecule quinolinium compound with no peptide bonds, unlike AOD-9604 which is a peptide fragment.

How large is the size difference?

Amino Fuel Labs records list 1815.08 g/mol for AOD-9604 and 159.21 g/mol for 5-Amino-1MQ.

Are they studied for the same purpose?

They are examined in different research contexts. 5-Amino-1MQ is described in enzyme-inhibition studies, while AOD-9604 is a growth-hormone-derived peptide fragment studied in metabolic research.

Are these approved for human use?

No. Both are supplied as research material only and are not for human or veterinary use.

Research Comparison Reference

AOD-9604 vs 5-Amino-1MQ: Peptide and Small-Molecule Comparison

A comparison across chemical classes: a growth-hormone-derived peptide fragment beside a small-molecule enzyme inhibitor.

Attribute comparison

Verified attribute comparison for AOD-9604 vs 5-Amino-1MQ: Peptide and Small-Molecule Comparison
Attribute	AOD-9604	5-Amino-1MQ
Compound class	Growth-hormone-derived peptide fragment	Small-molecule quinolinium compound
Peptide or non-peptide	Peptide	Non-peptide small molecule
Amino-acid count	Fragment sequence, see reference page	Not applicable
Receptor or pathway classification	Not established	NNMT enzyme inhibition (preclinical)
Molecular weight	1815.08 g/mol	159.21 g/mol
Physical form	Lyophilized powder	Lyophilized powder
Laboratory research context	Metabolic peptide fragment studies	Enzyme inhibition studies
Available from Amino Fuel Labs	Yes	Yes

Key structural differences

These two materials are not in the same chemical category. AOD-9604 is a peptide derived from a region of the human growth hormone sequence, with a molecular weight above eighteen hundred daltons.

5-Amino-1MQ is a small organic molecule near 159 g/mol, more than ten times lighter, and it contains no peptide bonds at all. It is classified in preclinical literature as an inhibitor of nicotinamide N-methyltransferase.

The class difference changes how each is handled analytically. A small molecule is typically characterized by different chromatographic conditions and detection than a peptide of this size.

Published research context

AOD-9604 has been investigated in preclinical metabolic research and in earlier clinical evaluation as an investigational compound. 5-Amino-1MQ has been examined in in-vitro and animal studies of NNMT inhibition.

Neither is an approved drug product and neither has an established human indication.

Frequently asked questions

Is 5-Amino-1MQ a peptide?: No. It is a small-molecule quinolinium compound with no peptide bonds, unlike AOD-9604 which is a peptide fragment.
How large is the size difference?: Amino Fuel Labs records list 1815.08 g/mol for AOD-9604 and 159.21 g/mol for 5-Amino-1MQ.
Are they studied for the same purpose?: They are examined in different research contexts. 5-Amino-1MQ is described in enzyme-inhibition studies, while AOD-9604 is a growth-hormone-derived peptide fragment studied in metabolic research.
Are these approved for human use?: No. Both are supplied as research material only and are not for human or veterinary use.

References

PubChem — 5-Amino-1MQ record search — National Center for Biotechnology Information
PubMed — AOD-9604 literature — National Library of Medicine
PubMed — NNMT inhibition literature — National Library of Medicine

Research use only. The information in this library is educational and is not medical advice. Products are not intended to diagnose, treat, cure, or prevent disease and are not for human or veterinary consumption.